34 Crystal-induced Osteoarthropathies and Related Diseases



10.1055/b-0034-77646

34 Crystal-induced Osteoarthropathies and Related Diseases

Helmberger, T., Staebler, A., Schmitt, R.

The term crystal-induced osteoarthropathy describes a heterogeneous group of joint diseases that are caused by disturbances in biochemical processes. Intraarticular precipitation and deposition of defined metabolic products sometimes induced characteristic osteoarthropathies. Crystal-induced osteoarthropathies include hyperuricemia (gouty arthritis), chondrocalcinosis (calcium pyrophosphate dihydrate [CPPD] crystal deposition disease), calcium hydroxyapatite crystal deposition disease, hemochromatosis, Wilson disease, alkaptonuria, and oxalosis. Typical radiographic findings characterize these disease entities.



Gouty Arthritis/Hyperuricemia





Pathoanatomy and Clinical Symptoms

Gouty arthritis is caused by elevated concentrations of uric acid in the extracellular space. The measurable correlate is uric acid in serum (normal value up to 6.5 mg/dl). By far the most common cause of primary gout is a combination of a genetically determined (so far not fully elucidated) disorder in renal excretion of uric acid (hereditary gout) with increased alimentary purine intake. The enzymatic defect (in phosphoribosyltransferase) responsible for the Lesch-Nyhan syndrome is a rare cause of increased synthesis of uric acid. Secondary gouty arthritis can be caused by a number of diseases that are not directly associated with the purinemetabolism but result in an increased accumulation of uric acid (e.g., myeloproliferative syndromes, leukemias) or to a decrease in renal excretion of uric acid (e.g., chronic kidney diseases). Gouty arthritis most commonly affects males in their fifties, with a predilection for the joints of the feet. Women are affected later and have milder disease and polyarticular manifestations.


When the solute capacity of uric acid is exceeded, sodium urate crystals precipitate in the kidneys and especially in the bradytrophic tissue of the joints. Gout of the joints has the following clinical symptoms:




  • Gouty arthritis most commonly presents as acute monarthritis (arthritis urica) in the following order of incidence: metatarsophalangeal joint of the big toe (podagra), metacarpophalangeal joint of the thumb (chiragra), the rest of the joints of the fingers and hand, and, less commonly, the large limb and iliosacral joints. During an acute attack of gouty arthritis, the urate crystals cause an extreme inflammatory reaction with redness, swelling, hyperthermia, and painful restriction of movement. Polarizing light-microscopic evidence of sodium [natrium]-monohydrate crystals in the synovial fluid constitutes proof of gout, but is usually unnecessary because of the unambiguous clinical presentation.



  • After a complaint-free interval, chronic recurrent attacks of gouty arthritis can set in.



  • Chronic gouty arthritis is characterized by the development of tophi in bones, bradytrophic tissues, and joints. Aside from polyarticular destructive osteoarthropathies, chronic deposition of urate crystals results in tophi in the subcutis, tendon sheaths, and bursae, and occasionally in Heberden nodules. In contrast to the remission state of acute gouty arthritis, chronic pain appears only in the stage of advanced joint destruction.



  • A special form, juvenile gouty arthritis (usually the Lesch-Nyhan syndrome), can have an aggressive course.



Diagnostic Imaging


Radiography

Radiographic examination is unremarkable in the first attack. In recurrent attacks, reversible periarticular osteopenia can appear. Typical articular lesions that can be seen in radiographs appear only in chronic cases lasting 5–10 years (Figs. 34.1a, 34.2a , 34.3 ), especially :




  • When calcinoses have developed in the presence of urate deposits (the urate crystals themselves are less radiodense)



  • When the initially slow destruction of the articular cartilage has become extensive.

Fig. 34.1a-c Chronic gouty arthritis of the third proximal interphalangeal joint. a The radiograph shows marginal and submarginal erosions with osteosclerotic margins on the proximal interphalangeal joint III. Slight periarticular soft-tissue swelling without calcifications. b The coronal T1-weighted SE sequence reveals sharply delineated, submarginal erosions of the head of the proximal phalanx and marginal erosions of the base of the middle phalanx. Massive thickening of articular soft tissues. The bone marrow of the proximal phalanx is hypointense in signal. c The fat-saturated T1-weighted SE sequence after administration of gadolinium shows strong enhancement of the erosive lesions and in the bone marrow of the proximal phalanx as a sign of medullary involvement in the inflammatory process.
Fig. 34.2a, b Synopsis of urate crystal deposition and joint erosions in gouty arthritis. a Grotesque gout tophi and deep, marginal erosions on the metacarpophalangeal joint of the thumb. Gouty thorn on the dorsal metacarpal head. b The combination of gout tophi in the periarticular and subcutaneous soft tissues and erosions is especially evident in CT. The flexor tendon is left free of deposits.
Fig. 34.3 Destructive form of gouty arthritis. Extensive cystic destruction of the carpus and all metacarpophalangeal and interphalangeal joints, some of which are subluxated. Intraosseous tophi with spotty calcifications on thehamate. Excessive soft-tissue tophi in the fingers and the carpus.

Table 34.1 summarizes the radiographic signs of gout.


Pharmacological treatment can make the soft-tissue calcifications disappear entirely, whereas erosive joint lesions and deformities remain without any reparativeprocesses.



Ultrasonography

Gout tophi are characteristically hyperechoic in high-resolution ultrasonography. Their hyperechoic appearance confirms the presence of gout, since lesions of nearly all other inflammatory entities are hypoechoic.



Computed Tomography

In CT, urate tophi have densities of about 170 HU (Fig. 34.2b). Although differentiation from calcified tophi and loose calcifications of other origin based on density can be problematic, gout can almost always be reliably differentiated from noncalcified soft-tissue masses, like xanthomas, in CT. Marginal erosions are characteristic.


















































Table 34.1 Radiographic signs of gout/hyperuricemia

I.   Acute gout attack


•   Periarticular soft-tissue swelling without calcification


•   Rarely widening of the joint space


II. Acute recurrent gout attacks


•   Reversible periarticular osteopenia


•   Flat, marginal erosions


III. Chronic gout


•   Focal deposition of urate crystals:


–     Gout tophi with periarticular, ligamentous, and subcutaneous chondrocalcinosis


–     Intraosseous tophus: focal calcification, bone infarct, cystic lesion


–     •   Erosions on the subchondral bone plate:


–     Marginal location on the border of the joint surface


–     Sharp contours with osteosclerotic margins


–     Early “mouse-or rat-bite” configuration


–     Later “punched-out” lesion and overhanging articular borders (gouty thorns) as a combination of erosions and osteophytic reaction


–     Narrowing of the radiographic joint space


–     Joint destruction with pathologic fractures and subluxations in the terminal stage


–     No osteoporosis


–     •   IV. Peculiarities in the hand


–     •   Carpometacarpal and interphalangeal joints are predisposed sites, especially the thumb


–     •   Tophi are more commonly located on the extensor tendons


–     •   Ulnar styloid process is deformed


The anatomic neighbourhood of urate deposits in the anatomically complex area of the carpus can be visualized better in CT than in projection radiography.



Magnetic Resonance Imaging

Inflammation of soft tissues, synovium, articular cartilage, and bones found in gouty arthritis can be detected in MR imaging earlier than in radiography (Fig. 34.1b, c). The inflamed areas have inhomogeneous, partially decreased signal intensity in T2-weighted sequences due to inclusions of tophi and possible hemorrhaging. In T1-weighted sequences, the tophi have an intermediate signal intensity. After intravenous administration of gadolinium, there is a moderate contrast enhancement in marginal erosions due to synovitis and less enhancement within the tophi.



Differential Diagnosis



  • During the initial manifestation, tenosynovitis and acute calcium deposition with hydroxyapatite crystals must also be considered.



  • The characteristic radiographic signs alone can exclude septicemic bacterial arthritis, rheumatoid arthritis, CPPD deposition disease, and diabetic osteoarthropathy during disease progression.



Therapeutic Options

Nonsteroidal anti-inflammatory drugs (NSAIDs) are the therapy of first choice for both acute gout attacks and chronic hyperuricemia. Acetylsalicylic acid is an exception because it decreases uric acid excretion. Glucocorticoids can be administered directly into the affected joint or systemically in the acute stage. Colchicine should only be prescribed when NSAIDs and corticoids are contraindicated because of its numerous side-effects. Chronic hyperuricemia is treated with diet and uricostatics or uricosurics.



Calcium Pyrophosphate Dihydrate (CPPD) Deposition Disease (Pyrophosphate Arthropathy)





Pathoanatomy and Clinical Symptoms

In this disease, calcium-pyrophosphate dihydrate (CPPD) crystals are deposited on the surfaces of the articular cartilage and the fibrous cartilage, and in the capsuloligamentary system. The two forms listed in Table 34.2 are differentiated pathoanatomically according to the type of crystal deposition.


Asymptomatic calcium pyrophosphate dihydrate deposits are often observed among the elderly, when the condition is termed chondrocalcinosis. In a high percentage of persons over 80 years of age, chondrocalcinosis is an incidental finding in the articular cartilage and causes no complaints. The most common sites of manifestation are the triangular fibrocartilage complex of the wrist, the menisci in the knees, the symphysis, and the articular cartilages. The familial occurrence of the disease indicates a genetic disposition. The manifestation generally begins before the age of 60 years in these cases.


If calcium pyrophosphate crystals are found, however, in the synovial fluid, CPPD deposition disease can become symptomatic.




  • calcium deposits in periarticular soft tissues cause monarthritic or polyarthritic complaints (pseudogout). During the pseudogout attack the joint is swollen, reddened, hyperthermic, and painful on pressure.



  • Deposits of CPPD in the joints can cause chronic destruction. Such cases are referred to as CPPD arthropathy.

Fig. 34.4a-c Diffuse form of calcium pyrophosphate dihydrate (CPPD) deposition disease. a In the dorsopalmar radiograph, there appear linear calcifications along the triangular fibrocartilage complex and focally in the scapholunate ligament and the flexor carpi ulnaris tendon. Cystic inclusions in the lunate. b Calcium deposits can be precisely localized in the scapholunate ligament in the sagittal multiplanar reconstruction of a high-resolution CT dataset. The cystic inclusions in the lunate correspond to intraosseous ganglion cysts originating from the scapholunate ligament. c In the axial CT source image, it is obvious that all segments of the scapholunate ligament are affected by chondrocalcinosis.




























Table 34.2 Types of calcium pyrophosphate dihydrate (CPPD) deposits

Parameter of CPPD


Diffuse Deposits


Focal Deposits


Incidence


Often


Rare


Predisposed site


Cartilage, joint capsule, and ligaments


None


Type of calcification


Homogeneous, not very dense, linear, spotty


Inhomogeneous, dense, coarse clumps


Space-occupying effect


None


So-called “tumorous chondrocalcinosis” with chronic inflammation

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jul 21, 2020 | Posted by in MUSCULOSKELETAL IMAGING | Comments Off on 34 Crystal-induced Osteoarthropathies and Related Diseases

Full access? Get Clinical Tree

Get Clinical Tree app for offline access